CDS-PD: A Novel Clinical Decision Support Platform for Parkinson's Disease

CDS-PD:一种新型的帕金森病临床决策支持平台

阅读:1

Abstract

OBJECTIVES: The Movement Disorders Society clinical diagnostic criteria for Parkinson's disease (MDS-PD) allow highly sensitive and specific diagnosis of Parkinson's disease. However, their adoption has been limited due to lack of a clinical decision support (CDS) tool to support clinicians and researchers in systematically and accurately applying the MDS-PD criteria. MATERIALS AND METHODS: We have developed and evaluated a CDS platform for PD (CDS-PD) as a modular and extensible informatics platform with comprehensive functionalities for recording relevant patient information. We have performed real time application of diagnostic algorithm of the MDS-PD criteria. RESULTS: The CDS-PD platform shows high concordance with application of the MDS-PD criteria by experienced movement disorders neurologists. DISCUSSION: The CDS-PD platform is a transformative step towards realizing the standardized electronic implementation of the MDS-PD criteria for PD patient care and clinical trials at point-of-care. CONCLUSION: The CDS-PD platform can be accessed after registration at weblink https://www.cdspd.org. LAY SUMMARY: Diagnostic criteria for Parkinson's disease (PD) have been developed to improve accuracy of clinical diagnosis of PD. However, these criteria are inherently complex to apply using a manual approach with pen-and-paper and are not supported in electronic health record systems. There is a need for a clinical decision support (CDS) system to support clinicians and researchers alike in the implementation of these criteria. We developed a novel technology platform to address this unmet need.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。